Emily Altman, MD
Dermatology · Atlanta, GANPI 1093794117
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,750 of the $8,011 with a category attached, or 71.8%. Eli Lilly accounts for 91.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $7,677 and has fallen 98.8% since, to $89 in 2023.
Across 60 payments — averaging $133.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$7K
- AbbVie$190
- Bristol Myers Squibb$156
- E.r. Squibb & Sons, L.L.C.$83
- Genentech USA, Inc.$63
- Sanofi$58
- plus $128 from 4 others
Across 14 payments — averaging $12,151 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$160K
- Eli Lilly$9K
- Sanofi US Services Inc.$1K
What the payments were for
- Consulting fees$5,75072%
- Travel & lodging$1,31616%
- Food & beverage$94512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 35 | $7,333 |
| AbbVie | 2 | $190 |
| Bristol Myers Squibb | 10 | $156 |
| E.r. Squibb & Sons, L.L.C. | 2 | $83 |
| Genentech USA, Inc. | 5 | $63 |
| Sanofi | 1 | $58 |
| Boehringer Ingelheim | 1 | $39 |
| Amgen | 2 | $39 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $31 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$123
How this compares
$8,011 in reported general payments places this provider in the 70th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 14 | $251 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Sumayah TaliaferroAtlanta$104K
- Sarah ChisolmAtlanta$59K
- Anna PareAtlanta$58K
- Lauren OrensteinAtlanta$52K
- Chelsie RogersAtlanta$43K
- Ron FeldmanAtlanta$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.